Imaginez un programme en 8 semaines qui puisse vous libérer du stress, de l'anxiété, de la déprime ou de la dépression simplement en vous enseignant de nouvelles manières de répondre à vos propres pensées et sentiments… Ce programme existe : c'est la thérapie cognitive basée sur la pleine conscience. Depuis de nombreuses années, il a fait ses preuves partout dans le monde.Ce manuel de méditation anti-déprime a été conçu comme une véritable immersion dans le programme. Vous y trouverez des méditations à faire chez vous semaine après semaine, des questions de réflexion, des outils pour mesurer vos progrès… Grâce aux nombreux exercices enregistrés, vous pourrez vous entraîner et vous exercer à tout moment, afin de tirer au maximum parti du programme.
Un livre pour vous guider pas à pas sur le chemin du changement !
Imaginez un programme en 8 semaines qui puisse vous libérer du stress, de l'anxiété, de la déprime ou de la dépression simplement en vous enseignant de nouvelles manières de répondre à vos propres pensées et sentiments… Ce programme existe : c'est la thérapie cognitive basée sur la pleine conscience. Depuis de nombreuses années, il a fait ses preuves partout dans le monde.Ce manuel de méditation anti-déprime a été conçu comme une véritable immersion dans le programme. Vous y trouverez des méditations à faire chez vous semaine après semaine, des questions de réflexion, des outils pour mesurer vos progrès… Grâce aux nombreux exercices enregistrés, vous pourrez vous entraîner et vous exercer à tout moment, afin de tirer au maximum parti du programme.
Un livre pour vous guider pas à pas sur le chemin du changement !
The largest meta-analysis to date of randomised controlled trials of mindfulness-based cognitive therapy (MBCT) for relapse prevention in recurrent depression was published in JAMA Psychiatry today. Here two of the co-authors on the paper, Catherine Crane and Zindel Segal reflect on its findings and ask “What do we know? What does it mean? Where to next?”
The largest meta-analysis to date of randomised controlled trials of mindfulness-based cognitive therapy (MBCT) for relapse prevention in recurrent depression was published in JAMA Psychiatry today. Here two of the co-authors on the paper, Catherine Crane and Zindel Segal reflect on its findings and ask “What do we know? What does it mean? Where to next?”
The largest meta-analysis to date of randomised controlled trials of mindfulness-based cognitive therapy (MBCT) for relapse prevention in recurrent depression was published in JAMA Psychiatry today. Here two of the co-authors on the paper, Catherine Crane and Zindel Segal reflect on its findings and ask “What do we know? What does it mean? Where to next?”
Le livre que vous tenez entre les mains est consacré aux techniques de méditation en pleine conscience. Associant tradition orientale et thérapie cognitive, ces techniques, scientifiquement validées, ont fait la preuve de leur efficacité. Non seulement elles aident à guérir et à prévenir la maladie dépressive, mais elles permettent, pratiquées régulièrement, de retrouver le goût simple de la vie. Lisez, pratiquez et jugez par vous-même ! « Ce guide lucide, à la fois rigoureux dans sa démarche scientifique et éclairant dans son approche pratique, offre une planche de salut pour retrouver la liberté intérieure, la joie de vivre et l'ouverture au monde, et pour éviter de sombrer à nouveau dans un gouffre sans lumière. » Matthieu Ricard. « Révolutionnaire... Un guide vraiment utile pour atteindre l'équilibre émotionnel. Je recommande au plus haut point ce livre et le CD qui l'accompagne. »Daniel Goleman, auteur de L'Intelligence émotionnelle. Mark Williams est professeur de psychologie clinique à l'Université d'Oxford en Grande-Bretagne. John Teasdale, chercheur, travaille au département de psychiatrie de l'Université d'Oxford et à l'unité de neurosciences de l'Université de Cambridge, en Grande-Bretagne. Zindel Segal, psychothérapeute, dirige l'unité de thérapie cognitivo-comportementale au centre Addiction et Santé mentale de Toronto, au Canada. Jon Kabat-Zinn est professeur émérite de médecine à l'Université du Massachusetts, aux États-Unis.
Le livre que vous tenez entre les mains est consacré aux techniques de méditation en pleine conscience. Associant tradition orientale et thérapie cognitive, ces techniques, scientifiquement validées, ont fait la preuve de leur efficacité. Non seulement elles aident à guérir et à prévenir la maladie dépressive, mais elles permettent, pratiquées régulièrement, de retrouver le goût simple de la vie. Lisez, pratiquez et jugez par vous-même ! « Ce guide lucide, à la fois rigoureux dans sa démarche scientifique et éclairant dans son approche pratique, offre une planche de salut pour retrouver la liberté intérieure, la joie de vivre et l'ouverture au monde, et pour éviter de sombrer à nouveau dans un gouffre sans lumière. » Matthieu Ricard. « Révolutionnaire... Un guide vraiment utile pour atteindre l'équilibre émotionnel. Je recommande au plus haut point ce livre et le CD qui l'accompagne. »Daniel Goleman, auteur de L'Intelligence émotionnelle. Mark Williams est professeur de psychologie clinique à l'Université d'Oxford en Grande-Bretagne. John Teasdale, chercheur, travaille au département de psychiatrie de l'Université d'Oxford et à l'unité de neurosciences de l'Université de Cambridge, en Grande-Bretagne. Zindel Segal, psychothérapeute, dirige l'unité de thérapie cognitivo-comportementale au centre Addiction et Santé mentale de Toronto, au Canada. Jon Kabat-Zinn est professeur émérite de médecine à l'Université du Massachusetts, aux États-Unis.
Zotero Collections:
Metacognitive awareness is a cognitive set in which negative thoughts/feelings are experienced as mental events, rather than as the self. The authors hypothesized that (a) reduced metacognitive awareness would be associated with vulnerability to depression and (b) cognitive therapy (CT) and mindfulness-based CT (MBCT) would reduce depressive relapse by increasing metacognitive awareness. They found (a) accessibility of metacognitive sets to depressive cues was less in a vulnerable group (residually depressed patients) than in nondepressed controls; (b) accessibility of metacognitive sets predicted relapse in residually depressed patients; (c) where CT reduced relapse in residually depressed patients, it increased accessibility of metacognitive sets; and (d) where MBCT reduced relapse in recovered depressed patients, it increased accessibility of metacognitive sets. CT and MBCT may reduce relapse by changing relationships to negative thoughts rather than by changing belief in thought content.
Metacognitive awareness is a cognitive set in which negative thoughts/feelings are experienced as mentalevents, rather than as the self. The authors hypothesized that (a) reduced metacognitive awareness would
be associated with vulnerability to depression and (b) cognitive therapy (CT) and mindfulness-based CT
(MBCT) would reduce depressive relapse by increasing metacognitive awareness. They found (a) accessibility of metacognitive sets to depressive cues was less in a vulnerable group (residually depressed patients) than in nondepressed controls; (b) accessibility of metacognitive sets predicted relapse in
residually depressed patients; (c) where CT reduced relapse in residually depressed patients, it increased
accessibility of metacognitive sets; and (d) where MBCT reduced relapse in recovered depressed patients,
it increased accessibility of metacognitive sets. CT and MBCT may reduce relapse by changing
relationships to negative thoughts rather than by changing belief in thought content.
Metacognitive awareness is a cognitive set in which negative thoughts/feelings are experienced as mentalevents, rather than as the self. The authors hypothesized that (a) reduced metacognitive awareness would
be associated with vulnerability to depression and (b) cognitive therapy (CT) and mindfulness-based CT
(MBCT) would reduce depressive relapse by increasing metacognitive awareness. They found (a) accessibility of metacognitive sets to depressive cues was less in a vulnerable group (residually depressed patients) than in nondepressed controls; (b) accessibility of metacognitive sets predicted relapse in
residually depressed patients; (c) where CT reduced relapse in residually depressed patients, it increased
accessibility of metacognitive sets; and (d) where MBCT reduced relapse in recovered depressed patients,
it increased accessibility of metacognitive sets. CT and MBCT may reduce relapse by changing
relationships to negative thoughts rather than by changing belief in thought content.
Mindfulness involves nonjudgmental attention to present-moment experience. In its therapeutic forms, mindfulness interventions promote increased tolerance of negative affect and improved well being. However, the neural mechanisms underlying mindful mood regulation are poorly understood. Mindfulness training appears to enhance attentional monitoring systems in the brain, supported by the anterior cingulate and lateral prefrontal cortices. In emotion regulation, this prefrontal training seems to promote the stable recruitment of a non-conceptual sensory pathway, an alternative to conventional cognitive reappraisal strategies. In neural terms, the transition to non-conceptual awareness involves reducing habitual evaluative processing supported by midline structures of the prefrontal cortex. Instead, attentional resources are directed towards a limbic pathway for present-moment sensory awareness, involving the thalamus, insula, and primary sensory regions. In patients with affective disorders, mindfulness training acts as an alternative to cognitive efforts to control emotion, instead directing attention towards broadly monitoring fluctuations in momentary experience. Limiting cognitive elaboration in favor of momentary awareness appears to reduce automatic negative self-evaluation, increase tolerance for negative affect and pain, and help to engender self-compassion and empathy in chronically dysphoric individuals.
Zotero Collections:
Mindfulness involves nonjudgmental attention to present-moment experience. In its therapeutic forms, mindfulness interventions promote increased tolerance of negative affect and improved well-being. However, the neural mechanisms underlying mindful mood regulation are poorly understood. Mindfulness training appears to enhance focused attention, supported by the anterior cingulate cortex and the lateral prefrontal cortex (PFC). In emotion regulation, these PFC changes promote the stable recruitment of a nonconceptual sensory pathway, an alternative to conventional attempts to cognitively reappraise negative emotion. In neural terms, the transition to nonconceptual awareness involves reducing evaluative processing, supported by midline structures of the PFC. Instead, attentional resources are directed toward a limbic pathway for present-moment sensory awareness, involving the thalamus, insula, and primary sensory regions. In patients with affective disorders, mindfulness training provides an alternative to cognitive efforts to control negative emotion, instead directing attention toward the transitory nature of momentary experience. Limiting cognitive elaboration in favour of momentary awareness appears to reduce automatic negative self-evaluation, increase tolerance for negative affect and pain, and help to engender self-compassion and empathy in people with chronic dysphoria.
Mindfulness involves nonjudgmental attention to present-moment experience. In its therapeutic forms, mindfulness interventions promote increased tolerance of negative affect and improved well-being. However, the neural mechanisms underlying mindful mood regulation are poorly understood. Mindfulness training appears to enhance focused attention, supported by the anterior cingulate cortex and the lateral prefrontal cortex (PFC). In emotion regulation, these PFC changes promote the stable recruitment of a nonconceptual sensory pathway, an alternative to conventional attempts to cognitively reappraise negative emotion. In neural terms, the transition to nonconceptual awareness involves reducing evaluative processing, supported by midline structures of the PFC. Instead, attentional resources are directed toward a limbic pathway for present-moment sensory awareness, involving the thalamus, insula, and primary sensory regions. In patients with affective disorders, mindfulness training provides an alternative to cognitive efforts to control negative emotion, instead directing attention toward the transitory nature of momentary experience. Limiting cognitive elaboration in favour of momentary awareness appears to reduce automatic negative self-evaluation, increase tolerance for negative affect and pain, and help to engender self-compassion and empathy in people with chronic dysphoria.
The development of the Mindfulness‐Based Cognitive Therapy Adherence Scale (MBCT‐AS) is described. This 17‐item scale measures therapist adherence to the treatment protocol for Mindfulness‐Based Cognitive Therapy (MBCT), a treatment for the prevention of recurrence in Major Depressive Disorder. The MBCT‐AS assesses therapist behaviours specific to (MBCT) as well as therapy practices that MBCT shares with Cognitive Behaviour Therapy (CBT). To determine the utility of this scale, we compared delivery of group MBCT against group CBT, with independent ratings of taped sessions provided to measure adherence to MBCT and CBT for therapists in both groups. The results showed that: (a) raters can reliably use the MBCT‐AS; (b) MBCT therapists demonstrated adherence to the treatment protocol, as measured by the MBCT‐AS; and (c) MBCT is distinguishable from CBT on both the MBCT‐AS and a scale measuring adherence to CBT (CBT‐AS). These findings indicate that the MBCT‐AS may be a useful tool for ensuring the proper delivery of MBCT in future research, and may be helpful in determining the elements of MBCT that are unique to that treatment.
This acclaimed work, now in a new edition, has introduced tens of thousands of clinicians to mindfulness-based cognitive therapy (MBCT) for depression, an 8-week program with proven effectiveness. Step by step, the authors explain the "whys" and "how-tos" of conducting mindfulness practices and cognitive interventions that have been shown to bolster recovery from depression and prevent relapse. Clinicians are also guided to practice mindfulness themselves, an essential prerequisite to teaching others. Forty-five reproducible handouts are included. Purchasers get access to a companion website featuring downloadable audio recordings of the guided mindfulness practices (meditations and mindful movement), plus all of the reproducibles, ready to download and print in a convenient 8 1/2" x 11" size. A separate website for use by clients features the audio recordings only.
This acclaimed work, now in a new edition, has introduced tens of thousands of clinicians to mindfulness-based cognitive therapy (MBCT) for depression, an 8-week program with proven effectiveness. Step by step, the authors explain the "whys" and "how-tos" of conducting mindfulness practices and cognitive interventions that have been shown to bolster recovery from depression and prevent relapse. Clinicians are also guided to practice mindfulness themselves, an essential prerequisite to teaching others. Forty-five reproducible handouts are included. Purchasers get access to a companion website featuring downloadable audio recordings of the guided mindfulness practices (meditations and mindful movement), plus all of the reproducibles, ready to download and print in a convenient 8 1/2" x 11" size. A separate website for use by clients features the audio recordings only.
This acclaimed work, now in a new edition, has introduced tens of thousands of clinicians to mindfulness-based cognitive therapy (MBCT) for depression, an 8-week program with proven effectiveness. Step by step, the authors explain the "whys" and "how-tos" of conducting mindfulness practices and cognitive interventions that have been shown to bolster recovery from depression and prevent relapse. Clinicians are also guided to practice mindfulness themselves, an essential prerequisite to teaching others. Forty-five reproducible handouts are included. Purchasers get access to a companion website featuring downloadable audio recordings of the guided mindfulness practices (meditations and mindful movement), plus all of the reproducibles, ready to download and print in a convenient 8 1/2" x 11" size. A separate website for use by clients features the audio recordings only.
<p>This book presents an innovative eight-session program designed to prevent relapse in clients who have recovered from depression.</p>
Zotero Collections:
This book presents an innovative eight-session program that has been clinically proven to bolster recovery from depression and prevent relapse. Developed by leading scientist-practitioners, and solidly grounded in current psychological research, the approach integrates cognitive therapy principles and practice into a mindfulness framework. Clinicians from any background will find vital tools to help clients maintain gains made by prior treatment and to expand the envelope of care to remission and beyond. The focus of mindfulness-based cognitive therapy is teaching clients how to make a simple yet radical shift in their relationship to the thoughts, feelings, and bodily sensations that contribute to depressive relapse. This shift entails fostering a "decentered" relationship to experience, in which negative thoughts or feelings can be viewed as events in the mind, rather than as "self" or as necessarily true. Step-by-step guidelines are provided for conducting awareness exercises and cognitive interventions that help clients both gain awareness of mild states of sadness and prevent them from spiraling out of control. Illustrative transcripts and a wealth of reproducible materials, including session summaries and participant forms, enhance the clinical utility of the volume. (PsycINFO Database Record (c) 2016 APA, all rights reserved)
This acclaimed work, now in a new edition, has introduced tens of thousands of clinicians to mindfulness-based cognitive therapy (MBCT) for depression, an 8-week program with proven effectiveness. Step by step, the authors explain the "whys" and "how-tos" of conducting mindfulness practices and cognitive interventions that have been shown to bolster recovery from depression and prevent relapse. Clinicians are also guided to practice mindfulness themselves, an essential prerequisite to teaching others. Forty-five reproducible handouts are included. Purchasers get access to a companion website featuring downloadable audio recordings of the guided mindfulness practices (meditations and mindful movement), plus all of the reproducibles, ready to download and print in a convenient 8 1/2" x 11" size. A separate website for use by clients features the audio recordings only. New to This Edition *Incorporates a decade's worth of developments in MBCT clinical practice and training. *Chapters on additional treatment components: the pre-course interview and optional full-day retreat. *Chapters on self-compassion, the inquiry process, and the three-minute breathing space. *Findings from multiple studies of MBCT's effectiveness and underlying mechanisms. Includes studies of adaptations for treating psychological and physical health problems other than depression. *Audio files of the guided mindfulness practices, narrated by the authors, on two separate Web pages--one for professionals, together with the reproducibles, and one just for clients. See also the authors' related titles for clients: The Mindful Way through Depression demonstrates these proven strategies in a self-help format, with in-depth stories and examples. The Mindful Way Workbook gives clients additional, explicit support for building their mindfulness practice, following the sequence of the MBCT program. Plus, for professionals: Mindfulness-Based Cognitive Therapy with People at Risk of Suicide extends and refines MBCT for clients with suicidal depression.
Objective:While mindfulness-based cognitive therapy (MBCT) has demonstrated efficacy in reducing depressive relapse/recurrence over 12–18 months, questions remain around effectiveness, longer-term outcomes, and suitability in combination with medication. The aim of this study was to investigate within a pragmatic study design the effectiveness of MBCT on depressive relapse/recurrence over 2 years of follow-up.
Method:
This was a prospective, multi-site, single-blind trial based in Melbourne and the regional city of Geelong, Australia. Non-depressed adults with a history of three or more episodes of depression were randomised to MBCT + depression relapse active monitoring (DRAM) (n=101) or control (DRAM alone) (n=102). Randomisation was stratified by medication (prescribed antidepressants and/or mood stabilisers: yes/no), site of usual care (primary or specialist), diagnosis (bipolar disorder: yes/no) and sex. Relapse/recurrence of major depression was assessed over 2 years using the Composite International Diagnostic Interview 2.1.
Results:
The average number of days with major depression was 65 for MBCT participants and 112 for controls, significant with repeated-measures ANOVA (F(1, 164)=4.56, p=0.03). Proportionally fewer MBCT participants relapsed in both year 1 and year 2 compared to controls (odds ratio 0.45, p<0.05). Kaplan-Meier survival analysis for time to first depressive episode was non-significant, although trends favouring the MBCT group were suggested. Subgroup analyses supported the effectiveness of MBCT for people receiving usual care in a specialist setting and for people taking antidepressant/mood stabiliser medication.
Conclusions:
This work in a pragmatic design with an active control condition supports the effectiveness of MBCT in something closer to implementation in routine practice than has been studied hitherto. As expected in this translational research design, observed effects were less strong than in some previous efficacy studies but appreciable and significant differences in outcome were detected. MBCT is most clearly demonstrated as effective for people receiving specialist care and seems to work well combined with antidepressants.
Objective:While mindfulness-based cognitive therapy (MBCT) has demonstrated efficacy in reducing depressive relapse/recurrence over 12–18 months, questions remain around effectiveness, longer-term outcomes, and suitability in combination with medication. The aim of this study was to investigate within a pragmatic study design the effectiveness of MBCT on depressive relapse/recurrence over 2 years of follow-up.
Method:
This was a prospective, multi-site, single-blind trial based in Melbourne and the regional city of Geelong, Australia. Non-depressed adults with a history of three or more episodes of depression were randomised to MBCT + depression relapse active monitoring (DRAM) (n=101) or control (DRAM alone) (n=102). Randomisation was stratified by medication (prescribed antidepressants and/or mood stabilisers: yes/no), site of usual care (primary or specialist), diagnosis (bipolar disorder: yes/no) and sex. Relapse/recurrence of major depression was assessed over 2 years using the Composite International Diagnostic Interview 2.1.
Results:
The average number of days with major depression was 65 for MBCT participants and 112 for controls, significant with repeated-measures ANOVA (F(1, 164)=4.56, p=0.03). Proportionally fewer MBCT participants relapsed in both year 1 and year 2 compared to controls (odds ratio 0.45, p<0.05). Kaplan-Meier survival analysis for time to first depressive episode was non-significant, although trends favouring the MBCT group were suggested. Subgroup analyses supported the effectiveness of MBCT for people receiving usual care in a specialist setting and for people taking antidepressant/mood stabiliser medication.
Conclusions:
This work in a pragmatic design with an active control condition supports the effectiveness of MBCT in something closer to implementation in routine practice than has been studied hitherto. As expected in this translational research design, observed effects were less strong than in some previous efficacy studies but appreciable and significant differences in outcome were detected. MBCT is most clearly demonstrated as effective for people receiving specialist care and seems to work well combined with antidepressants.
PURPOSE OF REVIEW:The article reviews the recent evidence for mindfulness-based cognitive therapy (MBCT) for patients with residual depressive symptoms or in remitted patients at increased risk for relapse.
RECENT FINDINGS:
Randomized controlled trials have shifted focus from comparing MBCT with treatment-as-usual to comparing MBCT against interventions. These studies have provided evidence for the efficacy of MBCT on par with maintenance antidepressant pharmacotherapy and leading to a relative reduction of risk on the order of 30-40%. Perhaps fuelled by these data, recent efforts have focused on extending MBCT to novel populations, such as acutely depressed patients, those diagnosed with health anxiety, social anxiety, fibromyalgia, or multiple chemical sensitivities as well migrating MBCT to online platforms so that it is more widely available. Neuroimaging studies of patients in structured therapies which feature mindfulness meditation, have reported findings that parallel behavioral changes, such as increased activation in brain regions subsuming self-focus and emotion regulation (prefrontal cortex) and interoceptive awareness (insula).
SUMMARY:
The current evidence base for MBCT is strongest for its application as a prophylactic intervention or for residual depressive symptoms, with early data suggesting additional indications outside the mood disorders. Future work will need to address dose-effect relationships between mindfulness practice and clinical benefits, as well as establishing the rates of uptake for online MBCT so that its benefits can be compared to in-person groups. Additionally, validating current or novel neural markers of MBCT treatment response will allow for patient matching and optimization of treatment response.
Pages |